By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Merit Medical Systems, Inc.

Merit Medical Systems, Inc. (MMSI)

NASDAQ Currency in USD
$90.21
+$1.42
+1.60%
Last Update: 11 Sept 2025, 20:00
$5.34B
Market Cap
45.79
P/E Ratio (TTM)
Forward Dividend Yield
$81.04 - $111.45
52 Week Range

MMSI Stock Price Chart

Explore Merit Medical Systems, Inc. interactive price chart. Choose custom timeframes to analyze MMSI price movements and trends.

MMSI Company Profile

Discover essential business fundamentals and corporate details for Merit Medical Systems, Inc. (MMSI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

14 May 1990

Employees

7.40K

CEO

Fred P. Lampropoulos

Description

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Financial Timeline

Browse a chronological timeline of Merit Medical Systems, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 22 Apr 2026

Upcoming earnings on 23 Feb 2026

Upcoming earnings on 29 Oct 2025

EPS estimate is $0.82, while revenue estimate is $371.69M.

Earnings released on 30 Jul 2025

EPS came in at $1.01 surpassing the estimated $0.86 by +17.44%, while revenue for the quarter reached $382.46M , beating expectations by +2.96%.

Earnings released on 24 Apr 2025

EPS came in at $0.86 surpassing the estimated $0.75 by +14.82%, while revenue for the quarter reached $355.35M , beating expectations by +0.80%.

Earnings released on 25 Feb 2025

EPS came in at $0.93 surpassing the estimated $0.82 by +13.41%, while revenue for the quarter reached $355.16M , beating expectations by +1.03%.

Earnings released on 30 Oct 2024

EPS came in at $0.86 surpassing the estimated $0.80 by +7.50%, while revenue for the quarter reached $339.85M , missing expectations by -2.06%.

Earnings released on 1 Aug 2024

EPS came in at $0.92 surpassing the estimated $0.88 by +4.55%, while revenue for the quarter reached $337.58M , beating expectations by +0.90%.

Earnings released on 30 Apr 2024

EPS came in at $0.77 surpassing the estimated $0.71 by +8.45%, while revenue for the quarter reached $323.51M , beating expectations by +2.55%.

Earnings released on 28 Feb 2024

EPS came in at $0.81 surpassing the estimated $0.77 by +5.19%, while revenue for the quarter reached $323.29M , beating expectations by +1.02%.

Earnings released on 26 Oct 2023

EPS came in at $0.75 surpassing the estimated $0.65 by +15.38%, while revenue for the quarter reached $315.23M , beating expectations by +2.93%.

Earnings released on 25 Jul 2023

EPS came in at $0.81 surpassing the estimated $0.75 by +8.00%, while revenue for the quarter reached $320.06M , beating expectations by +3.09%.

Earnings released on 26 Apr 2023

EPS came in at $0.64 surpassing the estimated $0.55 by +16.36%, while revenue for the quarter reached $297.57M , beating expectations by +6.10%.

Earnings released on 22 Feb 2023

EPS came in at $0.79 surpassing the estimated $0.67 by +17.91%, while revenue for the quarter reached $293.42M , beating expectations by +1.13%.

Earnings released on 26 Oct 2022

EPS came in at $0.64 surpassing the estimated $0.53 by +20.75%, while revenue for the quarter reached $287.18M , beating expectations by +5.38%.

Earnings released on 27 Jul 2022

EPS came in at $0.73 surpassing the estimated $0.58 by +25.86%, while revenue for the quarter reached $294.98M , beating expectations by +5.14%.

Earnings released on 27 Apr 2022

EPS came in at $0.53 surpassing the estimated $0.47 by +12.77%, while revenue for the quarter reached $275.42M , beating expectations by +4.18%.

Earnings released on 24 Feb 2022

EPS came in at $0.71 surpassing the estimated $0.50 by +42.00%, while revenue for the quarter reached $278.49M , beating expectations by +2.80%.

Earnings released on 28 Oct 2021

EPS came in at $0.52 surpassing the estimated $0.44 by +18.18%, while revenue for the quarter reached $267.02M , beating expectations by +2.69%.

Earnings released on 29 Jul 2021

EPS came in at $0.62 surpassing the estimated $0.44 by +40.91%, while revenue for the quarter reached $280.33M , beating expectations by +12.40%.

Earnings released on 29 Apr 2021

EPS came in at $0.52 surpassing the estimated $0.37 by +40.54%, while revenue for the quarter reached $248.91M , missing expectations by -0.61%.

Earnings released on 24 Feb 2021

EPS came in at $0.54 surpassing the estimated $0.43 by +25.58%, while revenue for the quarter reached $258.00M .

Earnings released on 28 Oct 2020

EPS came in at $0.42 surpassing the estimated $0.19 by +121.05%, while revenue for the quarter reached $243.98M , beating expectations by +19.72%.

MMSI Stock Performance

Access detailed MMSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run